Madrid Healthtech Startup Wilco Secures €2.5 Million to Expand AI Patient Follow-Up Platform Across Europe and Beyond

Wilco, a Madrid-based healthtech startup, has closed a €2.5 million Series A funding round to accelerate the expansion of its artificial intelligence-powered patient follow-up platform across Europe, the United States, and Latin America.

The funding round was led by Samaipata, with participation from ABAC Nest Ventures. The capital injection represents a significant milestone for the Spanish startup, which has developed a solution addressing a persistent challenge facing medical clinics: high patient drop-off rates between initial inquiry and actual appointment attendance.

Tackling Patient No-Shows with AI

Wilco’s platform automates patient communication through multiple channels, using AI-driven voice calls and messaging via WhatsApp to keep patients engaged throughout their treatment journey. The solution targets a widespread problem in the healthcare sector, where clinics frequently invest substantial resources in patient acquisition only to lose them before they receive care.

Francisco Hernández Parga, associated with the company, articulated the core problem the startup addresses: “Around artificial intelligence there is a lot of noise, but the problem for clinics is that they invest in attracting the patient and, too often, they lose them before they reach the consultation. Our job is to make sure that patient opens the door and accepts their treatment plan.”

Growth Plans and Resource Allocation

The newly secured capital will be deployed strategically across three primary areas. Wilco plans to reinforce its engineering team, bolstering its technical capabilities to enhance platform performance and reliability. Simultaneously, the company will expand its deployment and sales teams to manage growing customer acquisition and implementation efforts across new markets.

The funding will also support hiring initiatives across these core verticals as the startup scales operations. Beyond strengthening internal capabilities, the investment will directly fuel geographic expansion beyond Wilco’s current Spanish base into the broader European market, North America, and Latin America.

Positioning in the European Healthtech Landscape

The funding announcement reflects growing investor confidence in AI-driven healthcare solutions addressing operational inefficiencies in medical practices. As European regulators increasingly embrace digital health innovations and clinics across the continent face staffing pressures, automation solutions like Wilco’s platform are gaining traction.

The Madrid startup joins a growing cohort of European healthtech companies leveraging artificial intelligence to solve sector-specific problems. With this capital infusion and the backing of established venture investors, Wilco is positioning itself to become a significant player in the patient engagement space, particularly as clinics across multiple continents recognize the value of automated follow-up systems in improving patient outcomes and operational efficiency.

The company’s expansion trajectory will likely accelerate competition in the AI-powered patient communication segment, potentially spurring further innovation in how healthcare providers engage with patients across different markets and communication preferences.

Leave a Comment